Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.
about
In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii.Multidrug resistant acinetobacter.Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR.Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumanniiSynergistic activity and mechanism of action of Stephania suberosa Forman extract and ampicillin combination against ampicillin-resistant Staphylococcus aureusSynergism and the mechanism of action of the combination of α-mangostin isolated from Garcinia mangostana L. and oxacillin against an oxacillin-resistant Staphylococcus saprophyticus.Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan.Prevalence of carbapenemases among high-level aminoglycoside-resistant Acinetobacter baumannii isolates in a university hospital in China.In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii.Synergy and Mode of Action of Ceftazidime plus Quercetin or Luteolin on Streptococcus pyogenes.Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.Combating carbapenem-resistant Acinetobacter baumannii by an optimized imipenem plus tobramycin dosage regimen - prospective validation via hollow fiber infection and mathematical modeling.
P2860
Q33688501-C93DEBB6-A94C-4FA8-9A3C-4AC2F3C7F32DQ33711902-9277308F-1E13-4484-95B7-33C188B26766Q33970757-E9D14FAE-A45A-4484-99A5-C54735973D57Q33980337-72B58DAC-72AF-4671-8AF9-15E406832164Q34141308-998B0935-5CD4-4A9F-8295-4EF64970FCD6Q35168931-235A5F1F-D20E-41DC-88D9-70771B5ACEDFQ35596860-D4AB23CD-3D38-4A85-83F2-52CA689AE7DBQ36114756-EC67C754-8A98-40A0-BA46-674A78C4C214Q37420672-2B082554-067D-441B-98B1-FA115475F160Q37581669-BBF38ABB-7932-4588-AA0B-A3E960242B96Q37733474-F9B0B504-22DC-4104-8BFD-B1E3AD6EE830Q40862262-1C4CFEBC-9184-4715-9E15-F00AF6670B43Q40906997-E295DC53-ACFE-4B21-AD7E-3A4ADC601C1BQ41936281-3157E200-8301-4570-BB11-EA96D9F0483FQ47562492-45DCA146-A907-4DAC-8518-B229835AE41B
P2860
Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Comparative in vitro antimicro ...... ne antimicrobial combinations.
@ast
Comparative in vitro antimicro ...... ne antimicrobial combinations.
@en
type
label
Comparative in vitro antimicro ...... ne antimicrobial combinations.
@ast
Comparative in vitro antimicro ...... ne antimicrobial combinations.
@en
prefLabel
Comparative in vitro antimicro ...... ne antimicrobial combinations.
@ast
Comparative in vitro antimicro ...... ne antimicrobial combinations.
@en
P2093
P2860
P1476
Comparative in vitro antimicro ...... ne antimicrobial combinations.
@en
P2093
P2860
P304
P407
P577
1997-05-01T00:00:00Z